Dual CAR-NK cells targeting programmed death-ligand 1 (PD-L1) and human epidermal growth factor receptor (HER2) have shown enhanced cytotoxicity across diverse cancer cell lines, including breast, ovarian, pancreatic, and gastric cancer cells, when compared to mono-specific variants [7]. Here, ERBB2 is linked to gastric cancer.